Rankin G O, Beers K W, Nicoll D W, Anestis D K, Hong S K, Hubbard J L, Ball J G, Valentovic M A, Brown P I
Department of Pharmacology, Marshall University, Huntington, West Virginia 25704-9388, USA.
Toxicology. 1996 Apr 15;108(1-2):109-23. doi: 10.1016/0300-483x(95)03294-p.
Nephrotoxicity occurs following intraperitoneal (i.p.) administration of 2-chloroaniline or 4-chloroaniline hydrochloride to Fischer 344 rats, but the nephrotoxicant chemical species and mechanism of nephrotoxicity are unknown. The purpose of this study was to evaluate the in vivo and in vitro nephrotoxic potential of 2-amino-5-chlorophenol and 4-amino-3-chlorophenol, metabolites of 4-chloroaniline and 2-chloroaniline. A comparison was also made between the nephrotoxic potential of the aminochlorophenols and the corresponding aminophenols to examine the effect of adding a chloride group on the nephrotoxic potential of the animophenols. Male Fischer 344 rats (4/group) were given an i.p. injection of a chloroaniline or aminochlorophenol hydrochloride (1.5 mmol/kg), and aminophenol (1.0 or 1.5 mmol/kg), or vehicle, and renal function monitored at 24 and 48 h. Both aminochlorophenols induced smaller and fewer renal effects that the parent chloroanilenes in vivo. Also, 4-aminophenol was markedly more potent as a nephrotoxicant that 4-amino-3-chlorophenol, while 2-aminophenol and 2-amino-5-chlorophenol induced only mild change in renal function. In vitro, the phenolic compounds reduce p-aminohippurate accumulation by renal cortical slices at bath concentrations of 0.01 mM, while a bath concentration of 0.50 mM or greater was required for the chloroanilines. However, all compounds reduced tetraethylammonium accumulation at bath concentrations of 0.1-0.5 mM or greater. These results indicate that extrarenally-produced aminochlorophenol metabolites do not contribute to the mechanism of chloroaniline nephrotoxicity. Also, the reduced nephrotoxic potential of 4-amino-3-chlorophenol compared to 4-aminophenol could result from an altered ability of the aminochlorophenol to redox cycle or form conjugates.
给Fischer 344大鼠腹腔注射2-氯苯胺或4-氯苯胺盐酸盐后会出现肾毒性,但肾毒性化学物质种类和肾毒性机制尚不清楚。本研究的目的是评估2-氨基-5-氯苯酚和4-氨基-3-氯苯酚(4-氯苯胺和2-氯苯胺的代谢产物)的体内和体外肾毒性潜力。还对氨基氯苯酚和相应氨基酚的肾毒性潜力进行了比较,以研究添加氯基团对氨基酚肾毒性潜力的影响。雄性Fischer 344大鼠(每组4只)腹腔注射氯苯胺或氨基氯苯酚盐酸盐(1.5 mmol/kg)、氨基酚(l.0或1.5 mmol/kg)或赋形剂,并在24小时和48小时监测肾功能。两种氨基氯苯酚在体内引起的肾脏效应比母体氯苯胺更小、更少。此外,4-氨基酚作为肾毒物的效力明显高于4-氨基-3-氯苯酚,而2-氨基酚和2-氨基-5-氯苯酚仅引起肾功能的轻微变化。在体外,酚类化合物在浴液浓度为0.01 mM时可降低肾皮质切片对对氨基马尿酸的摄取,而氯苯胺则需要0.50 mM或更高的浴液浓度。然而,所有化合物在浴液浓度为0.1 - 0.5 mM或更高时均可降低四乙铵的摄取。这些结果表明,肾外产生的氨基氯苯酚代谢产物对氯苯胺肾毒性机制没有影响。此外,与4-氨基酚相比,4-氨基-3-氯苯酚肾毒性潜力降低可能是由于氨基氯苯酚氧化还原循环或形成共轭物的能力改变所致。